Literature DB >> 26300532

Long-term mortality of hospitalized pneumonia in the EPIC-Norfolk cohort.

P K Myint1, K R Hawkins2, A B Clark3, R N Luben4, N J Wareham5, K-T Khaw6, A M Wilson3.   

Abstract

Little is known about cause-specific long-term mortality beyond 30 days in pneumonia. We aimed to compare the mortality of patients with hospitalized pneumonia compared to age- and sex-matched controls beyond 30 days. Participants were drawn from the European Prospective Investigation into Cancer (EPIC)-Norfolk prospective population study. Hospitalized pneumonia cases were identified from record linkage (ICD-10: J12-J18). For this study we excluded people with hospitalized pneumonia who died within 30 days. Each case identified was matched to four controls and followed up until the end June 2012 (total 15 074 person-years, mean 6·1 years, range 0·08-15·2 years). Cox regression models were constructed to examine the all-cause, respiratory and cardiovascular mortality using date of pneumonia onset as baseline with binary pneumonia status as exposure. A total of 2465 men and women (503 cases, 1962 controls) [mean age (s.d.) 64·5 (8·3) years] were included in the study. Between a 30-day to 1-year period, hazard ratios (HRs) of all-cause and cardiovascular mortality were 7·3 [95% confidence interval (CI) 5·4-9·9] and 5·9 (95% CI 3·5-9·7), respectively (with very few respiratory deaths within the same period) in cases compared to controls after adjusting for age, sex, asthma, smoking status, pack years, systolic and diastolic blood pressure, diabetes, physical activity, waist-to-hip ratio, prevalent cardiovascular and respiratory diseases. All outcomes assessed also showed increased risk of death in cases compared to controls after 1 year; respiratory cause of death being the most significant during that period (HR 16·4, 95% CI 8·9-30·1). Hospitalized pneumonia was associated with increased all-cause and specific-cause mortality beyond 30 days.

Entities:  

Keywords:  All-cause mortality; cardiovascular mortality; long-term mortality; pneumonia; respiratory mortality

Mesh:

Year:  2015        PMID: 26300532      PMCID: PMC6217917          DOI: 10.1017/S0950268815001971

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  21 in total

1.  EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer.

Authors:  N Day; S Oakes; R Luben; K T Khaw; S Bingham; A Welch; N Wareham
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

2.  Medium-term survival after hospitalization with community-acquired pneumonia.

Authors:  Grant W Waterer; Lori A Kessler; Richard G Wunderink
Journal:  Am J Respir Crit Care Med       Date:  2003-12-23       Impact factor: 21.405

Review 3.  Burden of community-acquired pneumonia in North American adults.

Authors:  Thomas M File; Thomas J Marrie
Journal:  Postgrad Med       Date:  2010-03       Impact factor: 3.840

4.  Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia.

Authors:  Eric M Mortensen; Wishwa N Kapoor; Chung-Chou H Chang; Michael J Fine
Journal:  Clin Infect Dis       Date:  2003-11-20       Impact factor: 9.079

5.  Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted to secondary hospitals.

Authors:  Jong Hoo Lee; Yee Hyung Kim
Journal:  Braz J Infect Dis       Date:  2012 Jul-Aug       Impact factor: 1.949

6.  Hospitalized pneumonia. Outcomes, treatment patterns, and costs in urban and rural areas.

Authors:  J R Lave; M J Fine; S S Sankey; B H Hanusa; L A Weissfeld; W N Kapoor
Journal:  J Gen Intern Med       Date:  1996-07       Impact factor: 5.128

7.  Influence of comorbid conditions on long-term mortality after pneumonia in older people.

Authors:  Sachin Yende; Derek C Angus; Ibrahim Sultan Ali; Grant Somes; Anne B Newman; Douglas Bauer; Melissa Garcia; Tamara B Harris; Stephen B Kritchevsky
Journal:  J Am Geriatr Soc       Date:  2007-04       Impact factor: 5.562

8.  Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study.

Authors:  Jennie Johnstone; Dean T Eurich; Sumit R Majumdar; Yan Jin; Thomas J Marrie
Journal:  Medicine (Baltimore)       Date:  2008-11       Impact factor: 1.889

9.  Pneumonia mortality in a UK general practice population cohort.

Authors:  Puja R Myles; Richard B Hubbard; Jack E Gibson; Zara Pogson; Christopher J P Smith; Tricia M McKeever
Journal:  Eur J Public Health       Date:  2009-06-23       Impact factor: 3.367

10.  Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum.

Authors:  A Kumar; V Thota; L Dee; J Olson; E Uretz; J E Parrillo
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  3 in total

1.  Persistent Neuroinflammation and Brain-Specific Immune Priming in a Novel Survival Model of Murine Pneumosepsis.

Authors:  Scott J Denstaedt; Joanna L Spencer-Segal; Michael Newstead; Klaudia Laborc; Xianying Zeng; Theodore J Standiford; Benjamin H Singer
Journal:  Shock       Date:  2020-07       Impact factor: 3.533

2.  Factors associated with death in bedridden patients in China: A longitudinal study.

Authors:  Jing Cao; Tiantian Wang; Zhen Li; Ge Liu; Ying Liu; Chen Zhu; Jing Jiao; Jiaqian Li; Fangfang Li; Hongpeng Liu; Huaping Liu; Baoyun Song; Jingfen Jin; Yilan Liu; Xianxiu Wen; Shouzhen Cheng; Xia Wan; Xinjuan Wu
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

3.  Linking administrative data sets of inpatient infectious diseases diagnoses in far North Queensland: a cohort profile.

Authors:  Damon P Eisen; Emma S McBryde; Luke Vasanthakumar; Matthew Murray; Miriam Harings; Oyelola Adegboye
Journal:  BMJ Open       Date:  2020-03-18       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.